The industry fund has taken a 49 per cent stake in subscription vehicle provider Splend alongside IFM and other co-investors as it looks to build a 10 per cent exposure to climate solutions in its global portfolio.
After years of powering super returns into the double digits, US equities are walking a tightrope, and one misstep could send them plunging to earth. But the story that put them up there in the first place still holds true.
GMO in and Ramius out in BTFG alternatives shift
(pictured: Chris Thompson)
BT Financial Group is to shift about $800 million in international alternatives assets to GMO, with the US hedge fund-of-funds manager Ramius understood to be the main loser, in a rejig of its $3.2 billion alternatives portfolios for retail investors.
The move follows some significant personnel changes at BTFG, including the recent departure of Chris Thompson, who was head of alternatives for the last seven years. He had been at BTFG more than 10 years.
In May, BTFG chief executive Patrick Farrell left after nine years with the firm, to be replaced by the internal appointment of Martyn Wild. Farrell is now CIO of Suncorp.
Ramius had appointed nearly 20 underlying managers in the main Advance Alternatives Strategies multi-blend fund for BTFG, across six asset sub-classes, including cash. They included big-name managers such as BlackRock, AQR and Winton, and Australians Regal Funds Management and Kapstream for cash. The fund’s performance has been below benchmark over the past three years.
GMO, a value-oriented quant shop, is one of the few US-owned managers which runs one of its global strategies from Australia.
